REPHA GmbH Biologische Arzneimittel

Address
Alt-Godshorn 87, Godshorn

Sponsor Overview

assignment
2
sponsored trials
science
3
molecules
location_city
15
research centres
public
1
country
person_search
18
investigators

Specializations

Gastrointestinal Disorders

REPHA GmbH Biologische Arzneimittel focuses on clinical research in functional gastrointestinal disorders, with an emphasis on irritable bowel syndrome and its symptomatic burden.

  • Diarrhoea-predominant irritable bowel syndrome (IBS-D)
  • Mixed-type irritable bowel syndrome (IBS-M)
  • Digestive symptom management

The sponsor’s trial activity is centred on patient populations experiencing chronic bowel habit disturbance and related intestinal discomfort.

Symptom Relief and Tolerability

Its research interests include the evaluation of therapies for symptom control in IBS, with attention to both bowel-related outcomes and overall tolerability.

  • Diarrhoea control
  • Abdominal discomfort
  • Safety and tolerability

Clinical development is directed toward treatment options intended for patients with persistent gastrointestinal symptoms.

Placebo-Controlled Clinical Evaluation

The sponsor supports comparative clinical research in gastroenterology, using placebo-controlled assessment to examine therapeutic benefit in IBS-D and IBS-M.

  • Comparative efficacy
  • Clinical safety
  • Patient-reported symptom outcomes

This area reflects an interest in defining treatment effects in common bowel function disorders.

Therapeutic Development in Digestive Health

REPHA GmbH Biologische Arzneimittel is active in the development of digestive health therapies aimed at patients with chronic irritable bowel symptoms.

  • Natural-product-based medicinal research
  • Chronic bowel symptom treatment
  • Functional bowel disorder care

Its trial portfolio is concentrated in a single therapeutic domain, with ongoing studies in Germany across multiple research sites.

Sponsored Trials

Data & Insights

science
Molecule Portfolio
Compounds under investigation
3
Exclusive Molecules
out of 3 total (100% not shared with other sponsors)

This sponsor works with 3 molecules, of which 3 are not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
7%
Return partnership rate
1 of 15 sites collaborated multiple times

This sponsor has worked with 15 sites across their trial portfolio.

Therapeutic Focus

  • 1.
    Digestive System Diseases2 trials
    280 other sponsors

Partnered Research Centres

15 centres
location_city
assignment3
Centrum Gastroenterologie Bethanien
Address
Im Prüfling 21-25, 60389 Frankfurt
Learn morearrow_forward
location_city
assignment134
Charite Research Organisation GmbH
Address
Chariteplatz 1, 10117 Berlin
Learn morearrow_forward
location_city
assignment44
Eugastro GmbH
Address
Johannisplatz 1, Zentrum Sudost, 04103 Leipzig
Learn morearrow_forward
location_city
assignment48
Klinische Forschung Berlin GbR
Address
Ansbacher Strasse 17-19, Schoeneberg, 10787 Berlin
Learn morearrow_forward
location_city
assignment28
Klinische Forschung Berlin-Mitte GmbH
Address
Georgenstrasse 24, Mitte, 10117 Berlin
Learn morearrow_forward
location_city
assignment46
Klinische Forschung Dresden GmbH
Address
Prager Strasse 10, Seevorstadt-Ost/Grosser Garten, 01069 Dresden
Learn morearrow_forward
Page 1 of 3

Want to get in touch with this sponsor?

Send a question and we'll pass it on to REPHA GmbH Biologische Arzneimittel.

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.